Poly Medicure Limited — Important, 06-05-2025: General Updates

Poly Medicure has announced a board meeting to discuss the financial results for the quarter and half-year. The company launched a drug-eluting stent, successfully implanted in 100+ patients with positive feedback. Consolidated revenue rose 16.6% in Q4 and 21.4% for FY25; standalone revenue grew 16.6% and 22.5%. Export revenue increased 24% for FY25. EBITDA and PAT jumped 26.6% and 31.1%, with an EBITDA margin of 27.1%. Net cash remains strong at Rs 1219.6 Cr. Over 30 new products were launched, backed by a 60+ member R&D team.